Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss

SHEFFIELD, England, April 20, 2021 -- (Healthcare Sales & Marketing Network) -- Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today announces that it has raised a total of £10 million from exist... Regenerative Medicine, Venture Capital Rinri Therapeutics, stem cell, sensorineural hearing loss
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news